Since 1995, the Northwest Clinical Research Center has partnered with the pharmaceutical industry to conduct clinical research trials and is dedicated to providing quality medical treatment and patient safety. Each patient receives psychological assessments and health evaluations by our medical staff. Our specialty is psychiatry and the treatment of mood disorders.
ARIF KHAN, M.D.
Dr. Khan is a Board Certified Psychiatrist and Adjunct Professor of Psychiatry at Duke University School of Medicine. He is the Medical Director and Principal Investigator at NWCRC. Dr. Khan has been conducting clinical trials in the greater Seattle area since 1984 and founded NWCRC in 1995.
Dr. Khan has published more than 150 scientific papers. He serves as a reviewer for such journals as The Archives of General Psychiatry, The American Journal of Psychiatry, and Biological Psychiatry. He was extensively involved in research leading to the development of many medications that are now available today, such as Prozac, Zoloft, Paxil, Wellbutrin, Effexor, Serzone, Remeron, Celexa, Buspar, Zyprexa, Risperdal, Seroquel, Lexapro, Cymbalta, and Abilify.
Dr. Khan continues an active research career and presents his work at national and international scientific meetings. Click HERE to see Dr. Khan’s Curriculum Vitae or to read articles he has published.
GAYLON KIPP, M.D.
Dr. Kipp is a Board Certified primary care physician and has provided care to patients for over 30 years. He is currently a medical sub-investigator and has contributed to over 65 clinical trials here at NWCRC. When asked about his work, he says, “I enjoy patient contact and knowing that I’m making a difference through research.”